LFCR
HEALTHCARELifecore Biomedical Inc
$4.96-0.20 (-3.88%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving LFCR Today?
No stock-specific AI insight has been generated for LFCR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.63$8.98
$4.96
Fundamentals
Market Cap$186M
P/E Ratio—
EPS$-1.27
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume222K
Avg Volume (10D)—
Shares Outstanding37.5M
LFCR News
21 articles- Lifecore Biomedical Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate UpdateYahoo Finance·May 6, 2026
- Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026Yahoo Finance·Apr 29, 2026
- Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)Yahoo Finance·Apr 27, 2026
- Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Apr 22, 2026
- Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing SummitYahoo Finance·Apr 8, 2026
- Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCRGlobeNewswire Inc.·Apr 6, 2026
- When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)?Yahoo Finance·Apr 4, 2026
- Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical CustomerYahoo Finance·Mar 26, 2026
- Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics CompanyYahoo Finance·Mar 23, 2026
- Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029Marketbeat·Mar 20, 2026
- Lifecore Biomedical Inc (LFCR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·Mar 16, 2026
- Lifecore Biomedical Q4 Earnings Call HighlightsMarketbeat·Mar 16, 2026
- Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate UpdateYahoo Finance·Mar 16, 2026
- Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual ForumYahoo Finance·Mar 10, 2026
- Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026Yahoo Finance·Mar 9, 2026
- Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne TreatmentYahoo Finance·Mar 4, 2026
- Lifecore Biomedical to Participate at DCAT Week 2026Yahoo Finance·Feb 17, 2026
- Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Jan 16, 2026
- What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage?Yahoo Finance·Jan 16, 2026
- One Lifecore Biomedical Insider Raised Their Stake In The Previous YearYahoo Finance·Dec 20, 2025
All 21 articles loaded
Price Data
Open$4.95
Previous Close$5.16
Day High$5.16
Day Low$4.56
52 Week High$8.98
52 Week Low$3.63
52-Week Range
$3.63$8.98
$4.96
Fundamentals
Market Cap$186M
P/E Ratio—
EPS$-1.27
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume222K
Avg Volume (10D)—
Shares Outstanding37.5M
About Lifecore Biomedical Inc
Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally. The company is headquartered in Santa Maria, California.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—